Navigation Links
FDA approves Incivek for hepatitis C
Date:5/23/2011

SILVER SPRING, Md., May 23, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

The current standard of care for patients with chronic hepatitis C infection is peginterferon alfa and ribavirin taken for 48 weeks. Less than 50 percent of patients respond to this therapy.

The safety and effectiveness of Incivek was evaluated in three phase 3 clinical trials with about 2,250 adult patients who were previously untreated, or who had received prior therapy. In all studies patients also received the drug with standard of care. In previously untreated patients, 79 percent of those receiving Incivek experienced a sustained virologic response (i.e. the infection was no longer detected in the blood 24 weeks after stopping treatment) compared to standard treatment alone.

The sustained virologic response for patients treated with Incivek across all studies, and across all patient groups, was between 20 and 45 percent higher than current standard of care.

The studies indicate that treatment with Incivek can be shortened from 48 weeks to 24 weeks in most patients. Sixty percent of previously untreated patients achieved an early response and received only 24 weeks of treatment (compared to the standard of care of 48 weeks). The sustained virologic response for these patients was 90 percent.

When a person achieves a sustained virologic response after completing treatment, this suggests that the hepatitis C infection has been cured.

Sustain
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Sutent for Rare Type of Pancreatic Cancer
2. FDA Approves New HIV Treatment
3. FDA Approves Victrelis for Hepatitis C
4. FDA Approves New Treatment for Rare Type of Pancreatic Cancer
5. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
6. FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
7. FDA Approves New Treatment for Type 2 Diabetes
8. FDA Approves Zytiga for Late-Stage Prostate Cancer
9. FDA Approves Updated, Clarified Indication for Use for iFuse Implant System®
10. FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients
11. FDA Approves the First Vaccine to Prevent Meningococcal Disease in Infants and Toddlers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ... Reputation of Pharma in 2014 - a Perspective of ... to their offering. For the first time, ... corporate reputation of the pharmaceutical industry held by patient ... views of patient organisations representing all therapy areas. ...
(Date:4/16/2015)... 2015 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... and commercialization of products for the treatment of central ... for the first quarter of 2015 on Wednesday, May ... The Company will host a conference call at 4:30 ... Vanda management will discuss the first quarter 2015 financial ...
(Date:4/16/2015)... -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will report results ... May 6, 2015, following the close of the U.S. financial ... and live webcast on the same day at 5:00 p.m. ... financial results.  To access the webcast via ... link.  Please log onto the webcast prior to the start ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
... of Americans who are obese will increase to 164 million, ... years, a recent study says. 1 800 GET THIN ... individuals suffering from obesity and associated diseases resulting from obesity. ... and professionals we work with, is to attain a healthier ...
... a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: MSLP), ... announce MusclePharm,s preliminary financial results for the third quarter ... basis, the Company expects unaudited gross revenues for the ... an increase of 305% as compared to gross revenues ...
Cached Medicine Technology:1-800-GET-THIN Agrees With Report Calling for Better Eating Habits 2MusclePharm Announces Preliminary Third Quarter 2011 Results 2MusclePharm Announces Preliminary Third Quarter 2011 Results 3
(Date:4/18/2015)... (PRWEB) April 18, 2015 Patients who ... of developing mesothelioma later in life, but the disease ... mesothelioma that is unrelated to radiation. Surviving Mesothelioma has ... its website. Click here to read it now. ... compared the cases of 45 patients who had both ...
(Date:4/18/2015)... On April 14th, 2015, Symantec released Volume ... say, “exposes a tactical shift by cyberattackers.” With everything from ... in 2014 - almost a million a day - to ... identified and patched by prominent manufacturers – as long as ... in a digital world can be fraught with peril, and ...
(Date:4/18/2015)... 18, 2015 French physician and gastronome ... choices when he uttered, “Tell me what you eat, ... food to cope with stress or sadness has often ... indicates otherwise. Data collected from their Emotional ... to emotional eating, but for different reasons. , Collecting ...
(Date:4/17/2015)... Lynnwood, WA (PRWEB) April 17, 2015 ... seat cushions is introducing two new products to help ... seeking low back pain relief are the second most ... was our first product, designed specifically to help relieve ... the Comfort Cushion, and thousands of happy customers later, ...
(Date:4/17/2015)... have seen healing, a lot of healing, and a lot ... Kafader of Friendship Village. “People have found purpose. ... have created beautiful pieces of art.” For the past eight ... was launched to benefit residents of the retirement community. , ... Institute in Chicago, worked as an intern at Friendship Village, ...
Breaking Medicine News(10 mins):Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Healing At Friendship Village Due To Art Therapy 2
... to 20 percent of people infected with HIV, the ... into the brain, resulting in HIV-associated dementia and other ... of Medicine of Yeshiva University have found strong evidence ... bacteriaa chemical present in high levels in the blood ...
... Quarterly Reports use Market Intelligence and Competitive Analysis ... the Pharmaceutical Pipeline, LONDON and PHILADELPHIA, Aug. ... intelligent information for businesses and,professionals, has announced the ... period January-March 2008. Launched more than two years,ago, ...
... many commonly used ... prescription medications, FRANKLIN LAKES, N.J., Aug. ... leading pharmacy benefit manager,announced it and the Food and Drug Administration ... the impact of genetics on,the efficacy of prescription drugs. The announcement ...
... of new study say aim is to generate awareness of ... trauma patients are less likely to be transported to an ... new study found. , The finding was based on a ... services (EMS) records. And it suggests that the difference in ...
... has,completed construction and received licensing from the Arizona ... Unit (ICU) and officially,opened August 13th, 2008. The ... the,following Saturday. Construction of Gilbert Hospital,s three-bed ICU ... The ICU is located in a,remodeled area of ...
... (VA) will open three Veterans Rural Health Resource,Centers on ... veterans and,develop special practices and products to implement across ... areas, the nearest medical center can,be miles away," said ... provide the best quality care to veterans regardless of ...
Cached Medicine News:Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 2Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 3Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 4Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 2Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 3Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 2Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 3Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 4Health News:Older Patients Less Likely to Be Taken to Trauma Centers 2Health News:Older Patients Less Likely to Be Taken to Trauma Centers 3Health News:New Intensive Care Unit at Gilbert Hospital Sees First Patient 2
... provides the adaptability surgeons need to make ... other way around. The wide selection of ... components allow surgeons to address the unexpected ... all with one instrument set. For cruciate ...
... knee manufacturers focus attention on implant design, ... The Profix Total Knee System seeks to ... implant system and the tools to implant ... widely recognized for innovation in total knee ...
Cemented hip system...
... new generation of posterior stabilized knee ... the following: Patellar flange mates with ... machined condyles assure precise, repeatable kinematics ... and patella to reduce wear. Constant ...
Medicine Products: